These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 12569958)
1. Therapeutic use of botulinum toxins: background and history. Setler PE Clin J Pain; 2002; 18(6 Suppl):S119-24. PubMed ID: 12569958 [TBL] [Abstract][Full Text] [Related]
2. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction. Lew MF Clin J Pain; 2002; 18(6 Suppl):S142-6. PubMed ID: 12569961 [TBL] [Abstract][Full Text] [Related]
6. The binding of botulinum neurotoxins to different peripheral neurons. Rossetto O Toxicon; 2018 Jun; 147():27-31. PubMed ID: 29042309 [TBL] [Abstract][Full Text] [Related]
7. Possible mechanisms for the effects of botulinum toxin on pain. Arezzo JC Clin J Pain; 2002; 18(6 Suppl):S125-32. PubMed ID: 12569959 [TBL] [Abstract][Full Text] [Related]
8. A focused review on the use of botulinum toxins for neuropathic pain. Argoff CE Clin J Pain; 2002; 18(6 Suppl):S177-81. PubMed ID: 12569966 [TBL] [Abstract][Full Text] [Related]
9. Introduction to the Toxins Special Issue on Botulinum Neurotoxins in the Nervous System: Future Challenges for Novel Indications. Luvisetto S Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32957443 [No Abstract] [Full Text] [Related]
10. Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use. Hambleton P J Neurol; 1992 Jan; 239(1):16-20. PubMed ID: 1311751 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products. Dessy LA; Fallico N; Mazzocchi M; Scuderi N Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763 [TBL] [Abstract][Full Text] [Related]
16. Botulinum toxins: mechanisms of action, antinociception and clinical applications. Wheeler A; Smith HS Toxicology; 2013 Apr; 306():124-46. PubMed ID: 23435179 [TBL] [Abstract][Full Text] [Related]
17. Pharmacology of botulinum neurotoxin serotype A. Wenzel RG Am J Health Syst Pharm; 2004 Nov; 61(22 Suppl 6):S5-10. PubMed ID: 15598004 [TBL] [Abstract][Full Text] [Related]
18. Re-engineering clostridial neurotoxins for the treatment of chronic pain: current status and future prospects. Pickett A BioDrugs; 2010 Jun; 24(3):173-82. PubMed ID: 20462283 [TBL] [Abstract][Full Text] [Related]
19. Unlabeled uses of botulinum toxins: a review, part 1. Cheng CM; Chen JS; Patel RP Am J Health Syst Pharm; 2006 Jan; 63(2):145-52. PubMed ID: 16390928 [TBL] [Abstract][Full Text] [Related]
20. Recovery from botulinum neurotoxin poisoning in vivo. Keller JE Neuroscience; 2006 May; 139(2):629-37. PubMed ID: 16490322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]